BioTrinity is the leading European Biopartnering and Investment Conference. It provides the best opportunity to meet investors, senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies.
Now in its 9th year, the de facto national biopartnering conference is expected once again to attract 1000+ delegates from over 30 countries. The new, dedicated MediTrinity stream will attract key personnel from medtech corporates and diagnostics R&D companies.
At the heart of the event are the world class speaker programme, compelling panels of experts and the powerhouse partnering system.